Annalisa Saltari
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma.
Journal: Nature cancer
Published: December 01, 2023
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma.
Journal: Cancer research
Published: June 03, 2022
Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research.
Journal: Journal of visualized experiments : JoVE
Published: July 26, 2021
Microgreens: Functional Food with Antiproliferative Cancer Properties Influenced by Light.
Journal: Foods (Basel, Switzerland)
Published: June 07, 2021
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression.
Journal: Cancer research
Published: January 29, 2021
STK11 Prevents Invasion through Signal Transducer and Activator of Transcription 3/5 and FAK Repression in Cutaneous Melanoma.
Journal: The Journal of investigative dermatology
Published: November 20, 2020
Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.
Journal: International journal of molecular sciences
Published: April 12, 2017
Metastatic melanoma moves on: translational science in the era of personalized medicine.
Journal: Cancer metastasis reviews
Published: March 22, 2017
Last Updated: 09/26/2026